With extensive experience in the finance sector, Daniel Ronan has established himself as a key figure in capital markets. His professional journey encompasses various leadership roles where he demonstrated expertise in driving financial growth and fostering strong stakeholder relationships. Notably, his strategic insights into market dynamics have made him an invaluable asset to firms seeking to navigate complex investment landscapes. Daniel's proven ability to leverage analytical skills with business acumen positions him uniquely within corporate leadership circles, highlighting his relevance in identifying opportunities that enhance organizational performance.
With extensive experience in the finance sector, Daniel Ronan has established himself as a key figure in capital markets. His professional journey encompasses various leadership roles where he demonstrated expertise in driving financial growth and fostering strong stakeholder relationships. Notably, his strategic insights into market dynamics have made him an invaluable asset to firms seeking to navigate complex investment landscapes. Daniel's proven ability to leverage analytical skills with business acumen positions him uniquely within corporate leadership circles, highlighting his relevance in identifying opportunities that enhance organizational performance.
Recognizing emerging trends and their potential impact on markets often underpins decision-making for Daniel Ronan. His investment strategy emphasizes deep analytical insights, allowing him to discern opportunities in complex environments. A keen understanding of capital flows combined with a robust network enables the pursuit of unique growth avenues that can capitalize on shifting economic landscapes. By fostering innovation within teams and prioritizing operational excellence, he strives to create substantial value through strategic investments that enhance performance over time.
Recognizing emerging trends and their potential impact on markets often underpins decision-making for Daniel Ronan. His investment strategy emphasizes deep analytical insights, allowing him to discern opportunities in complex environments. A keen understanding of capital flows combined with a robust network enables the pursuit of unique growth avenues that can capitalize on shifting economic landscapes. By fostering innovation within teams and prioritizing operational excellence, he strives to create substantial value through strategic investments that enhance performance over time.
| Trades 3793 | Longs Won 2611/3793 68% | Profit Factor 20.7 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $770,217.18 |
| Average Win $145,612.9 | Best Trade (Aug 14) $25.35M | Sharpe Ratio -16.7 |
| Average Loss -$15,540.45 | Worst Trade (Sep 14) -$979,740.26 | Z-Score 25.41 (100%) |
| Commissions $0 | Avg. Trade Length 1y 7m 1d | Expectancy $95,359.01 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 66,667 | 60,000 | 53,333 | 46,667 | 40,000 | 33,333 | 26,667 | 20,000 | 13,333 | 6,667 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
A Agilent Technologies Inc. | 1,616 | $214,653 | $223,605.92 | - | $8,952.92 | 4.17% | -0.245% |
AAPL Apple Inc. | 129,671 | $23.78M | $40.06M | - | $16.27M | 68.42% | -7.354% |
ABBV AbbVie Inc. | 15,393 | $2.7M | $3.86M | - | $1.16M | 42.86% | -2.513% |
ABOS Acumen Pharmaceuticals, Inc. | 89,699 | $431,452 | $192,852.85 | - | -$238,599.15 | -55.3% | -0.922% |
ABT Abbott Laboratories | 10,696 | $1.17M | $1.13M | - | -$40,236.41 | -3.44% | +0.085% |
ACGL Arch Capital Group Ltd | 2,664 | $258,568 | $267,811.92 | - | $9,243.92 | 3.58% | -0.603% |
ACN Accenture plc Class A | 4,544 | $830,239.64 | $753,940.48 | - | -$76,299.16 | -9.19% | +1.611% |
ACWI iShares MSCI ACWI ETF | 82,074 | $11.77M | $12.84M | - | $1.07M | 9.11% | +0.495% |
ACWX ISHARES MSCI ACWI EX U.S. ETF | 41,024 | $2.35M | $3.09M | - | $733,348.58 | 31.16% | -0.172% |
ADBE Adobe Inc. | 1,358 | $406,172.68 | $340,056.78 | - | -$66,115.9 | -16.28% | +1.013% |
ADI Analog Devices, Inc. | 3,123 | $703,144.1 | $1.15M | - | $444,277.33 | 63.18% | +0.202% |
ADP Automatic Data Processing Inc. | 2,850 | $697,264.02 | $759,410.97 | - | $62,146.95 | 8.91% | +0.982% |
AEP American Electric Power Company, Inc. | 2,497 | $272,120.93 | $319,241.45 | - | $47,120.52 | 17.32% | +0.055% |
AFL Aflac Inc. | 2,774 | $308,913.03 | $353,629.52 | - | $44,716.49 | 14.48% | +0.094% |
AGG iShares Core U.S. Aggregate Bond ETF | 297,735 | $29.24M | $28.99M | - | -$251,828.31 | -0.86% | -0.256% |
AIG American International Group Inc. | 6,575 | $434,534.64 | $516,663.5 | - | $82,128.86 | 18.9% | -0.393% |
AIZ Assurant Inc. | 1,124 | $166,047.93 | $313,809.56 | - | $147,761.63 | 88.99% | -1.158% |
AJG Arthur J. Gallagher & Co. | 1,396 | $352,639.04 | $348,190.32 | - | -$4,448.72 | -1.26% | -2.745% |
AKAM Akamai Technologies Inc. | 15,772 | $1.27M | $1.82M | - | $547,828.87 | 43.18% | +1.257% |
ALL Allstate Corporation | 2,840 | $608,297.63 | $749,987.16 | - | $141,689.53 | 23.29% | -0.49% |